Towa Pharmaceutical Co., Ltd. (FRA:6QC)
Germany
· Delayed Price · Currency is EUR 17.20
-0.20 (-1.15%)
Last updated: Dec 3, 2025, 8:13 AM CET
Towa Pharmaceutical Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 909 | 815 | 876 | 646 | 1,006 | 926 | Upgrade
|
| Market Cap Growth | -1.89% | -6.98% | 35.63% | -35.82% | 8.64% | -1.83% | Upgrade
|
| Enterprise Value | 1,942 | 2,015 | 1,890 | 1,544 | 1,447 | 1,443 | Upgrade
|
| Last Close Price | 18.10 | 15.98 | 17.13 | 12.26 | 18.34 | - | Upgrade
|
| PE Ratio | 7.65 | 6.95 | 8.84 | 42.38 | 8.53 | 8.61 | Upgrade
|
| PS Ratio | 0.59 | 0.51 | 0.63 | 0.45 | 0.82 | 0.78 | Upgrade
|
| PB Ratio | 0.88 | 0.77 | 0.92 | 0.68 | 1.03 | 1.03 | Upgrade
|
| P/TBV Ratio | 1.16 | 1.05 | 1.36 | 1.11 | 1.74 | 1.18 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 12.35 | 41.88 | Upgrade
|
| P/OCF Ratio | 5.48 | 5.64 | 17.41 | 36.67 | 6.13 | 10.01 | Upgrade
|
| EV/Sales Ratio | 1.32 | 1.26 | 1.35 | 1.07 | 1.18 | 1.21 | Upgrade
|
| EV/EBITDA Ratio | 7.88 | 7.52 | 8.68 | 8.95 | 6.62 | 6.17 | Upgrade
|
| EV/EBIT Ratio | 15.15 | 14.03 | 17.48 | 40.43 | 10.53 | 9.40 | Upgrade
|
| EV/FCF Ratio | -297.87 | - | - | - | 17.76 | 65.24 | Upgrade
|
| Debt / Equity Ratio | 1.31 | 1.38 | 1.32 | 1.26 | 1.09 | 0.73 | Upgrade
|
| Debt / EBITDA Ratio | 5.30 | 5.45 | 5.80 | 6.94 | 4.89 | 2.79 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 13.12 | 29.53 | Upgrade
|
| Asset Turnover | 0.58 | 0.58 | 0.57 | 0.60 | 0.57 | 0.65 | Upgrade
|
| Inventory Turnover | 1.51 | 1.58 | 1.51 | 1.64 | 1.43 | 1.61 | Upgrade
|
| Quick Ratio | 1.28 | 1.33 | 1.26 | 1.00 | 0.73 | 1.33 | Upgrade
|
| Current Ratio | 2.80 | 2.81 | 2.72 | 2.33 | 1.45 | 2.67 | Upgrade
|
| Return on Equity (ROE) | 12.18% | 11.59% | 11.05% | 1.64% | 12.79% | 12.62% | Upgrade
|
| Return on Assets (ROA) | 3.14% | 3.22% | 2.75% | 0.98% | 4.03% | 5.26% | Upgrade
|
| Return on Capital (ROIC) | 3.64% | 3.77% | 3.28% | 1.18% | 4.85% | 6.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 6.10% | 5.00% | 1.90% | 8.60% | 10.30% | Upgrade
|
| Earnings Yield | 13.07% | 14.40% | 11.31% | 2.36% | 11.72% | 11.61% | Upgrade
|
| FCF Yield | -0.72% | -4.04% | -20.74% | -28.07% | 8.10% | 2.39% | Upgrade
|
| Dividend Yield | 2.73% | 2.71% | 2.15% | 3.39% | 2.30% | - | Upgrade
|
| Payout Ratio | 16.94% | 15.55% | 18.25% | 140.84% | 15.15% | 15.52% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | 0.00% | 2.19% | 1.86% | 3.57% | Upgrade
|
| Total Shareholder Return | 2.71% | 2.70% | 2.15% | 5.58% | 4.16% | 3.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.